Please assess the completion status of the following clinical trial:

Trial Title: Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients undergoing total knee arthroplasty~Exclusion Criteria:~* bilateral total knee arthroplasty~* hematochromatosis or hemosiderosis~* hemolytic anemia~* history of drug allergy~* liver cirrhosis or hepatitis~* systematic lupus erythematosus~* rheumatic arthritis~* allergic disease~* history of transfusion within one month from surgery~* parturient

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Patients in this group would receive Iron Isomaltoside 1000 (Monofer®) after main procedure of total knee arthroplasty. The dose of iron isomaltoside would be determined based on the patient's body weight.
- Control (Type: NO_INTERVENTION): Patients in this group would receive 100ml of normal saline after main procedure of total knee arthroplasty.

Based on this trial design, predict the completion outcome and termination type (if applicable).